204 related articles for article (PubMed ID: 36316281)
1. How Structure-Function Relationships of 1,4-Naphthoquinones Combat Antimicrobial Resistance in Multidrug-Resistant (MDR) Pathogens.
Mone NS; Syed S; Ravichandiran P; Satpute SK; Kim AR; Yoo DJ
ChemMedChem; 2023 Jan; 18(2):e202200471. PubMed ID: 36316281
[TBL] [Abstract][Full Text] [Related]
2. Synergistic and Additive Effects of Menadione in Combination with Antibiotics on Multidrug-Resistant Staphylococcus aureus: Insights from Structure-Function Analysis of Naphthoquinones.
Mone NS; Syed S; Ravichandiran P; Kamble EE; Pardesi KR; Salunke-Gawali S; Rai M; Vikram Singh A; Prasad Dakua S; Park BH; Yoo DJ; Satpute SK
ChemMedChem; 2023 Dec; 18(24):e202300328. PubMed ID: 37874976
[TBL] [Abstract][Full Text] [Related]
3. Foodborne ESKAPE Biofilms and Antimicrobial Resistance: lessons Learned from Clinical Isolates.
Patil A; Banerji R; Kanojiya P; Saroj SD
Pathog Glob Health; 2021 Sep; 115(6):339-356. PubMed ID: 33851566
[TBL] [Abstract][Full Text] [Related]
4. Multidrug-Resistant and Virulent Organisms Trauma Infections: Trauma Infectious Disease Outcomes Study Initiative.
Mende K; Akers KS; Tyner SD; Bennett JW; Simons MP; Blyth DM; Li P; Stewart L; Tribble DR
Mil Med; 2022 May; 187(Suppl 2):42-51. PubMed ID: 35512375
[TBL] [Abstract][Full Text] [Related]
5. Characterisation of ESKAPE Pathogens with Special Reference to Multidrug Resistance and Biofilm Production in a Nepalese Hospital.
Pandey R; Mishra SK; Shrestha A
Infect Drug Resist; 2021; 14():2201-2212. PubMed ID: 34163185
[TBL] [Abstract][Full Text] [Related]
6. Molecular characterization of multidrug-resistant ESKAPEE pathogens from clinical samples in Chonburi, Thailand (2017-2018).
Ruekit S; Srijan A; Serichantalergs O; Margulieux KR; Mc Gann P; Mills EG; Stribling WC; Pimsawat T; Kormanee R; Nakornchai S; Sakdinava C; Sukhchat P; Wojnarski M; Demons ST; Crawford JM; Lertsethtakarn P; Swierczewski BE
BMC Infect Dis; 2022 Aug; 22(1):695. PubMed ID: 35978294
[TBL] [Abstract][Full Text] [Related]
7. Mechanisms of Antimicrobial Resistance in ESKAPE Pathogens.
Santajit S; Indrawattana N
Biomed Res Int; 2016; 2016():2475067. PubMed ID: 27274985
[TBL] [Abstract][Full Text] [Related]
8. Antimicrobial Resistance in ESKAPE Pathogens.
De Oliveira DMP; Forde BM; Kidd TJ; Harris PNA; Schembri MA; Beatson SA; Paterson DL; Walker MJ
Clin Microbiol Rev; 2020 Jun; 33(3):. PubMed ID: 32404435
[TBL] [Abstract][Full Text] [Related]
9. Coping with the ESKAPE pathogens: Evolving strategies, challenges and future prospects.
Aloke C; Achilonu I
Microb Pathog; 2023 Feb; 175():105963. PubMed ID: 36584930
[TBL] [Abstract][Full Text] [Related]
10. Update on the main MDR pathogens: prevalence and treatment options.
Esposito S; De Simone G
Infez Med; 2017 Dec; 25(4):301-310. PubMed ID: 29286008
[TBL] [Abstract][Full Text] [Related]
11. Multi-drug resistant ESKAPE pathogens and the uses of plants as their antimicrobial agents.
Idris FN; Nadzir MM
Arch Microbiol; 2023 Mar; 205(4):115. PubMed ID: 36917278
[TBL] [Abstract][Full Text] [Related]
12. Antibacterial activities of and biofilm removal by Ablysin, an endogenous lysozyme-like protein originated from Acinetobacter baumannii 1656-2.
Kim S; Jin JS; Lee DW; Kim J
J Glob Antimicrob Resist; 2020 Dec; 23():297-302. PubMed ID: 33045439
[TBL] [Abstract][Full Text] [Related]
13. Quantifying the Evolutionary Conservation of Genes Encoding Multidrug Efflux Pumps in the ESKAPE Pathogens To Identify Antimicrobial Drug Targets.
Brooks LE; Ul-Hasan S; Chan BK; Sistrom MJ
mSystems; 2018; 3(3):. PubMed ID: 29719870
[TBL] [Abstract][Full Text] [Related]
14. Antimicrobial Resistance in
Lupo A; Haenni M; Madec JY
Microbiol Spectr; 2018 Jun; 6(3):. PubMed ID: 30101740
[TBL] [Abstract][Full Text] [Related]
15. A Whole-Cell Screen Identifies Small Bioactives That Synergize with Polymyxin and Exhibit Antimicrobial Activities against Multidrug-Resistant Bacteria.
Zimmerman SM; Lafontaine AJ; Herrera CM; Mclean AB; Trent MS
Antimicrob Agents Chemother; 2020 Feb; 64(3):. PubMed ID: 31844003
[TBL] [Abstract][Full Text] [Related]
16. Norfloxacin salts of carboxylic acids curtail planktonic and biofilm mode of growth in ESKAPE pathogens.
Lowrence RC; Ramakrishnan A; Sundaramoorthy NS; Shyam A; Mohan V; Subbarao HMV; Ulaganathan V; Raman T; Solomon A; Nagarajan S
J Appl Microbiol; 2018 Feb; 124(2):408-422. PubMed ID: 29178633
[TBL] [Abstract][Full Text] [Related]
17. Emerging Strategies to Combat ESKAPE Pathogens in the Era of Antimicrobial Resistance: A Review.
Mulani MS; Kamble EE; Kumkar SN; Tawre MS; Pardesi KR
Front Microbiol; 2019; 10():539. PubMed ID: 30988669
[TBL] [Abstract][Full Text] [Related]
18. Sulopenem: An Intravenous and Oral Penem for the Treatment of Urinary Tract Infections Due to Multidrug-Resistant Bacteria.
Zhanel GG; Pozdirca M; Golden AR; Lawrence CK; Zelenitsky S; Berry L; Schweizer F; Bay D; Adam H; Zhanel MA; Lagacé-Wiens P; Walkty A; Irfan N; Naber K; Lynch JP; Karlowsky JA
Drugs; 2022 Apr; 82(5):533-557. PubMed ID: 35294769
[TBL] [Abstract][Full Text] [Related]
19. Photodynamic therapy for ESKAPE pathogens: An emerging approach to combat antimicrobial resistance (AMR).
Mathur A; Parihar AS; Modi S; Kalra A
Microb Pathog; 2023 Oct; 183():106307. PubMed ID: 37604213
[TBL] [Abstract][Full Text] [Related]
20. Going Beyond Host Defence Peptides: Horizons of Chemically Engineered Peptides for Multidrug-Resistant Bacteria.
Cavallazzi Sebold B; Li J; Ni G; Fu Q; Li H; Liu X; Wang T
BioDrugs; 2023 Sep; 37(5):607-623. PubMed ID: 37300748
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
